| Imidazopyridine, a promising scaffold with potential medicinal applications and structural activity relationship (SAR): recent advances S Khatun, A Singh, GN Bader, FA Sofi Journal of Biomolecular Structure and Dynamics 40 (24), 14279-14302, 2022 | 25 | 2022 |
| Reactive metabolites from thiazole-containing drugs: Quantum chemical insights into biotransformation and toxicity CK Jaladanki, S Khatun, H Gohlke, PV Bharatam Chemical research in toxicology 34 (6), 1503-1517, 2021 | 19 | 2021 |
| Are inhibitors of histone deacetylase 8 (HDAC8) effective in hematological cancers especially acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL)? SA Amin, S Khatun, S Gayen, S Das, T Jha European Journal of Medicinal Chemistry, 115594, 2023 | 7 | 2023 |
| A detail survey and analysis of selectivity criteria for indole-based histone deacetylase 8 (HDAC8) inhibitors M Moinul, SA Amin, S Khatun, S Das, T Jha, S Gayen Journal of Molecular Structure 1271, 133967, 2023 | 7 | 2023 |
| Recent trends in fragment-based anticancer drug design strategies against different targets: A mini-review M Moinul, S Khatun, SA Amin, T Jha, S Gayen Biochemical Pharmacology 206, 115301, 2022 | 6 | 2022 |
| Binary quantitative activity-activity relationship (QAAR) studies to explore selective HDAC8 inhibitors: In light of mathematical models, DFT-based calculation and molecular … SA Amin, J Kumar, S Khatun, S Das, IA Qureshi, T Jha, S Gayen Journal of Molecular Structure 1260, 132833, 2022 | 6 | 2022 |
| Identification of structural fingerprints among natural inhibitors of HDAC1 to accelerate nature-inspired drug discovery in cancer epigenetics S Sardar, Jyotisha, SA Amin, S Khatun, IA Qureshi, UK Patil, T Jha, ... Journal of Biomolecular Structure and Dynamics, 1-15, 2023 | 2 | 2023 |
| In Silico Discovery of Class IIb HDAC Inhibitors: The State of Art S Khatun, SA Amin, S Gayen, T Jha Current Trends in Computational Modeling for Drug Discovery, 25-55, 2023 | 1 | 2023 |
| Quasi-SMILES as a Tool for Peptide QSAR Modelling M Moinul, S Khatun, S Abdul Amin, T Jha, S Gayen QSPR/QSAR Analysis Using SMILES and Quasi-SMILES, 269-294, 2023 | 1 | 2023 |
| Remdesivir: Mechanism of Metabolic Conversion from Prodrug to Drug S Kapoor, G Dubey, S Khatun, PV Bharatam Current Drug Metabolism 23 (1), 73-81, 2022 | 1 | 2022 |
| HDAC9 as a Privileged Target: Reviewing its Role in Different Diseases and Structure-activity Relationships (SARs) of its Inhibitors T Das, S Khatun, T Jha, S Gayen Mini Reviews in Medicinal Chemistry 24 (7), 767-784, 2024 | | 2024 |
| Advances in structure-activity relationships of HDAC inhibitors as HIV latency-reversing agents S Khatun, SA Amin, D Choudhury, B Chowdhury, T Jha, S Gayen Expert Opinion on Drug Discovery, 1-16, 2024 | | 2024 |
| 11 Modeling Inhibitors S Khatun, SA Amin, S Banerjee, S Gayen, T Jha Modeling Inhibitors of Matrix Metalloproteinases, 368, 2023 | | 2023 |
| Reactive Metabolites from Thiazole-containing Drugs: Quantum Chemical Insights into Biotransformation and Toxicity PVB S Khatun, CK Jaladanki https://t3-1.conventus-hetzner.de/fileadmin/GPTS_2021_Abstract_booklet.pdf, 2021 | | 2021 |
